BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Business

  Amgen 2021 Revenue Propped up by COVID-19 Manufacturing Collab

  Much of Amgen’s modest gains in the year can be attributed to its manufacturing partnership with Eli Lilly and an increase in sales for EVENITY.

  February 8, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Alzheon Alzheimer’s Asset Poised for Phase III with High Hopes

  ALZ-801 is administered orally and works by blocking the formation of neurotoxic soluble amyloid oligomers that later lead to cognitive decline in Alzheimer’s patients.

  February 8, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Pharm Country

  COVID Update: Pill Production Underway and Vaccines in Pregnant Women

  Antiviral pills against COVID-19 show promise for treating the disease, but they are not broadly accessible yet.

  February 8, 2022

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  Astellas Gene Therapy for Pompe Disease Clears Important Safety Hurdle

  Weston Miller, M.D., senior medical director of clinical development at Astellas Gene Therapies, called the positive interim and tolerability data an important waypoint.

  February 8, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Business

  Bayer Poaches GSK’s Christine Roth as Others Shuffle the Executive Deck

  Bayer isn’t the only company to announce changes to its leadership team this morning. Editas, Biogen, Takeda, Merck and Vedere Bio also announced leadership changes.

  February 8, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Business

  White House Science Adviser Resigns Following Bullying Reports

  After allegations of bullying became public, Dr. Eric Lander, the director of the federal government’s Office of Science and Technology Policy, resigned from his executive branch role.

  February 8, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  CRISPR Pioneer Doudna Joins Global Investment Firm as CSO

  Jennifer Doudna will act as Chief Science Advisor to build a Scientific Advisory Board for Sixth Street, advising the investment firm on CRISPR-related opportunities.

  February 8, 2022

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Business

  Montreal-based Biotech Snags $50M to Build Team of “Drug Hunters”

  The new funds will go toward advancing Congruence’s Revenir™ platform, a computational tool that models diseases that come from cellular proteins misfolding in order to understand them better.

  February 8, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Policy

  WuXi’s Shares Plunge as Commerce Dept. Adds it to “Unverified List”

  WuXi Biologics was amongst those on the list, with the U.S. stating that it was unable to verify the legitimacy and reliability of the company in its use of U.S. exports.

  February 8, 2022

   · 

  2 min read
• 

  Business

  Companies Making the Biggest Bucks from COVID-19 Therapeutics Sales

  Here’s a look at five companies that produced non-vaccine treatments for COVID-19.

  February 8, 2022

   · 

  4 min read

   · 

  Mark Terry